Relaxin inhibits cardiac fibrosis and endothelial-mesenchymal transition via the Notch pathway.
about
Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic DiseasesEndothelial-Mesenchymal Transition in Regenerative MedicineRUNX3 modulates hypoxia-induced endothelial-to-mesenchymal transition of human cardiac microvascular endothelial cells.Nupr1/Chop signal axis is involved in mitochondrion-related endothelial cell apoptosis induced by methamphetamineSpirolactone provides protection from renal fibrosis by inhibiting the endothelial-mesenchymal transition in isoprenaline-induced heart failure in rats.Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions.Novel Anti-fibrotic Therapies.Notch Signaling in Ischemic Damage and Fibrosis: Evidence and Clues from the Heart.TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases.Relaxin ameliorates high glucose-induced cardiomyocyte hypertrophy and apoptosis via the Notch1 pathway.Serelaxin Induces Notch1 Signaling and Alleviates Hepatocellular Damage in Orthotopic Liver Transplantation.Endothelial to Mesenchymal Transition Represents a Key Link in the Interaction between Inflammation and Endothelial Dysfunction.Effects of exposure of adult mice to multi-walled carbon nanotubes on the liver lipid metabolism of their offspringOxymatrine Inhibits Transforming Growth Factor β1 (TGF-β1)-Induced Cardiac Fibroblast-to-Myofibroblast Transformation (FMT) by Mediating the Notch Signaling Pathway In VitroExendin‑4 reverses endothelial dysfunction in mice fed a high‑cholesterol diet by a GTP cyclohydrolase‑1/tetrahydrobiopterin pathway
P2860
Q26748338-09C909D3-A636-4B43-B7BF-F50C142B21AFQ26752901-2F1B35E7-E4AB-4874-A782-67D27A8E31F9Q33783985-FC1D327B-BD96-4FD3-A938-0FE51BDD929CQ36775049-3CEDA9EC-36E3-4F14-99F2-A65076247EDCQ36887421-57765B23-916F-4911-939D-6C60BE40092FQ38649653-03939FDE-BDBF-440A-A36E-6A10B3711EEAQ39377055-7487035B-0FE5-46D8-90DB-E88DB9FE36D5Q42292750-A67E3215-E0FC-4FB1-A163-F81A9B181C9BQ44537770-134B03E5-FF8F-4159-B7E9-432BF43C60A6Q49211871-DB478B7D-0A67-4BF5-AB28-E763A9C0192CQ49718692-8A459ECA-BB77-4FEC-BC09-E64C6DBBF3F0Q54982965-26C44F49-A44F-40D2-98BA-16689DF94FC9Q57497802-D4D9D546-D6C6-4D9D-AB7E-4C91399907C0Q58757229-0474997D-EEE1-48D9-AF6A-EE94FA45AB6DQ58805576-DB1C72F1-CB78-4A41-9D6B-F4EFA6A4E8CC
P2860
Relaxin inhibits cardiac fibrosis and endothelial-mesenchymal transition via the Notch pathway.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Relaxin inhibits cardiac fibro ...... nsition via the Notch pathway.
@ast
Relaxin inhibits cardiac fibro ...... nsition via the Notch pathway.
@en
type
label
Relaxin inhibits cardiac fibro ...... nsition via the Notch pathway.
@ast
Relaxin inhibits cardiac fibro ...... nsition via the Notch pathway.
@en
prefLabel
Relaxin inhibits cardiac fibro ...... nsition via the Notch pathway.
@ast
Relaxin inhibits cardiac fibro ...... nsition via the Notch pathway.
@en
P2093
P2860
P356
P1476
Relaxin inhibits cardiac fibro ...... nsition via the Notch pathway.
@en
P2093
P2860
P304
P356
10.2147/DDDT.S85399
P407
P577
2015-08-11T00:00:00Z